Search

everythinglearnresearchcommunity

for

Search:↓

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

Anifrolumab effectively improved symptoms and reduced steroid use in Japanese patients with systemic lupus erythematosus.

Erythrocyte-anchored nanoparticles improved Cepharanthine delivery and effectiveness for treating acute lung injury.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

Most patients successfully switched from the original adalimumab to a biosimilar with few reverting due to reduced effectiveness or side effects.

PEA-ENL improves skin delivery and reduces inflammation without side effects.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

Dupilumab effectively treats various inflammatory skin diseases beyond its initial use for atopic dermatitis.

A medication for skin rash also unexpectedly treated hair loss in a patient.

Selective immunotherapies like anifrolumab and belimumab are more effective for treating systemic lupus erythematosus than traditional drugs.

The technology can help diagnose and subtype autoimmune diseases by identifying specific autoantibodies.

PRAME helps distinguish between benign and malignant skin cells in most cases.

Upadacitinib effectively treats pyoderma gangrenosum.

Blocking IL-8 can reduce skin rashes from cancer treatment.

Eupafolin nanoparticles help protect skin cells from damage caused by air pollution.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

Rizatriptan benzoate-loaded dissolving microneedles are effective and convenient for treating acute migraines.

Dupilumab effectively improves skin conditions, reduces symptoms, and enhances quality of life in certain dermatological issues.

Adalimumab can cause complete hair loss in rare cases.

Adalimumab helped control a child's severe eye disease when other treatments failed.

Dupilumab improved severe atopic dermatitis in a patient who didn't respond to other treatments.

17β-estradiol boosts APE1/Ref-1 secretion in cells and mice via a calcium-dependent pathway.

Rapamycin and anti-EGFR antibody reduce LAM/TSC cell migration and blood vessel growth in the uterus.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

Promising cancer treatments were found, but the manufacturer closed.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

BMPR1a-ECD reduces wrinkles much more effectively than retinoic acid.

Patients with acute and subacute skin lupus respond faster to belimumab than those with chronic skin lupus.

The antibody 005-C04 blocks prolactin receptors, causing reversible infertility, impaired lactation, and hair regrowth in female mice.